News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
243 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17856)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (249)
2 (227)
3 (175)
4 (72)
5 (2)
6 (9)
7 (175)
8 (219)
9 (161)
10 (259)
11 (113)
12 (7)
13 (2)
14 (172)
15 (304)
16 (260)
17 (238)
18 (120)
19 (1)
20 (3)
21 (214)
22 (269)
23 (243)
24 (278)
25 (118)
26 (3)
27 (18)
28 (238)
29 (307)
30 (277)
31 (323)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Deals
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Oct. 23, 2019
PTC Therapeutics, Inc. announced that on October 18, 2019 it approved non-statutory stock options to purchase an aggregate of 144,150 shares of its common stock to 29 new employees.
October 23, 2019
·
1 min read
Business
NextGen Healthcare, Inc. Reports Fiscal 2020 Second Quarter
On a GAAP basis, revenue for the fiscal 2020 second quarter was $134.3 million compared to $130.3 million a year ago.
October 23, 2019
·
12 min read
Deals
Charles River Laboratories Announces Closing of Senior Notes Offering - Oct. 23, 2019
Charles River Laboratories International, Inc. announced that it has closed its previously announced offering of $500 million in aggregate principal amount of its 4.25% senior notes due 2028 in an unregistered offering.
October 23, 2019
·
3 min read
Business
TherapeuticsMD Announces Estimated Third Quarter 2019 Financial Results
Company estimates that its consolidated net revenue from its prescription vitamin business will range from approximately $2.50 million to $2.60 million
October 23, 2019
·
6 min read
Business
Georgia Dental Association Continues To Fight Opioid Epidemic
Oct. 26 is National Prescription Drug Take Back Day—a day to not only safely dispose of unused prescription medications but also to raise year-round awareness and inspire further action on the opioid public health crisis.
October 23, 2019
·
2 min read
FDA
GSK Announces U.S. Food and Drug Administration Approval of Additional Indication for Zejula (niraparib) for Late-line Treatment for Women with Recurrent Ovarian Cancer
Expanded indication allows for treatment of women whose advanced ovarian cancer is associated with homologous recombination deficiency (HRD)
October 23, 2019
·
10 min read
Business
Jon Roth, CEO, Announces Resignation
It was with mixed emotions that the California Pharmacists Association Board of Trustees announce that Jon R. Roth, MS, CAE has resigned as Chief Executive Officer of the California Pharmacists Association.
October 23, 2019
·
2 min read
Business
Genomma Lab Internacional Reports Third Quarter 2019 Results
Genomma Lab Internacional, S.A.B. de C.V., announced its results for the second quarter ended June 30, 2019.
October 23, 2019
·
4 min read
Policy
Pharmascience Inc. issues voluntary recall of Ranitidine Tablets 75mg, 150mg and 300mg (all pack sizes and formats)
Pharmascience Inc. is voluntarily, on a precautionary basis, recalling Ranitidine Tablets 75mg, 150mg and 300 mg to the retail level.
October 23, 2019
·
2 min read
Business
Invacare Corporation to Host Conference Call and Webcast to Discuss Third Quarter 2019 Financial Results
The company will provide a live conference call and webcast to discuss these financial results on Thursday, November 7, 2019 at 8:30 AM ET.
October 23, 2019
·
2 min read
Previous
7 of 25
Next